Who Holds Parabilis Medicines, Inc. (PBLS)? 79 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 79 holders, $2.7 billion in total.
Largest holders
The 79 largest by value. Change in shares against the quarter before.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 28,933,371 | $792 million | New | 13F |
| FMR LLC | 10,292,735 | $282 million | New | 13F |
| ARCH Venture Management, LLC | 6,412,780 | $176 million | New | 13F |
| venBio Partners LLC | 5,266,697 | $144 million | New | 13F |
| Alphabet Inc. | 4,919,498 | $135 million | New | 13F |
| Nextech Invest Ltd. | 4,663,176 | $128 million | New | 13F |
| Cormorant Asset Management, LP | 4,615,612 | $126 million | New | 13F |
| REGENERON PHARMACEUTICALS, INC. | 4,166,666 | $114 million | New | 13F |
| Siren, L.L.C. | 2,992,259 | $82 million | New | 13F |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2,368,200 | $65 million | New | 13F |
| Jupiter Topco LLC | 2,296,547 | $63 million | New | 13F |
| Frazier Life Sciences Management, L.P. | 1,920,805 | $53 million | New | 13F |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,880,704 | $51 million | New | 13F |
| General Catalyst Group Management, LLC | 1,600,937 | $44 million | New | 13F |
| GENERAL ATLANTIC, L.P. | 1,538,461 | $42 million | New | 13F |
| Soleus Capital Management, L.P. | 1,465,070 | $40 million | New | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,302,479 | $36 million | New | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,156,962 | $32 million | New | 13F |
| JPMORGAN CHASE & CO | 1,042,772 | $30 million | New | 13F |
| Foresite Capital Management VI LLC | 999,044 | $27 million | New | 13F |
| Catalio Capital Management, LP | 824,043 | $23 million | New | 13F |
| ALLIANCEBERNSTEIN L.P. | 810,279 | $22 million | New | 13F |
| Casdin Capital, LLC | 645,690 | $18 million | New | 13F |
| Venrock Adviser, LLC | 625,000 | $17 million | New | 13F |
| Rock Springs Capital Management LP | 578,028 | $16 million | New | 13F |
| SAMSARA BIOCAPITAL, LLC | 556,044 | $15 million | New | 13F |
| Logos Global Management LP | 525,000 | $14 million | New | 13F |
| Bellevue Group AG | 500,000 | $14 million | New | 13F |
| BAKER BROS. ADVISORS LP | 500,000 | $14 million | New | 13F |
| MARSHALL WACE, LLP | 445,359 | $12 million | New | 13F |
| FRANKLIN RESOURCES INC | 381,487 | $10 million | New | 13F |
| ICONIQ Capital, LLC | 350,000 | $10 million | New | 13F |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 295,962 | $8 million | New | 13F |
| Kynam Capital Management, LP | 250,000 | $7 million | New | 13F |
| FEDERATED HERMES, INC. | 246,200 | $7 million | New | 13F |
| AMERIPRISE FINANCIAL INC | 174,773 | $5 million | New | 13F |
| Driehaus Capital Management LLC | 100,000 | $3 million | New | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 99,358 | $3 million | New | 13F |
| TD Asset Management Inc | 76,982 | $2 million | New | 13F |
| Squarepoint Ops LLC | 48,484 | $1 million | New | 13F |
| TUDOR INVESTMENT CORP ET AL | 44,045 | $1 million | New | 13F |
| UBS Group AG | 38,698 | $1 million | New | 13F |
| WINTON GROUP Ltd | 34,900 | $955,213 | New | 13F |
| VANGUARD FIDUCIARY TRUST CO | 27,800 | $760,886 | New | 13F |
| Balyasny Asset Management L.P. | 24,264 | $664,106 | New | 13F |
| Hudson Bay Capital Management LP | 22,690 | $621,025 | New | 13F |
| Brevan Howard Capital Management LP | 22,565 | $617,604 | New | 13F |
| Ghisallo Capital Management LLC | 20,000 | $547,400 | New | 13F |
| Mitsubishi UFJ Asset Management Co., Ltd. | 19,200 | $525,504 | New | 13F |
| Vanguard Personalized Indexing Management, LLC | 11,729 | $321,023 | New | 13F |
| SEVEN GRAND MANAGERS, LLC | 10,000 | $273,700 | New | 13F |
| Burkehill Global Management, LP | 10,000 | $273,700 | New | 13F |
| Alyeska Investment Group, L.P. | 10,000 | $273,700 | New | 13F |
| ExodusPoint Capital Management, LP | 9,691 | $265,243 | New | 13F |
| Scientech Research LLC | 9,564 | $261,767 | New | 13F |
| TWO SIGMA INVESTMENTS, LP | 8,741 | $239,241 | New | 13F |
| GOLDMAN SACHS GROUP INC | 8,253 | $225,885 | New | 13F |
| Persistent Asset Partners Ltd | 4,130 | $113,038 | New | 13F |
| Tower Research Capital LLC (TRC) | 2,070 | $56,656 | New | 13F |
| CITIGROUP INC | 1,869 | $51,155 | New | 13F |
| China Universal Asset Management Co., Ltd. | 1,600 | $43,792 | New | 13F |
| WELLS FARGO & COMPANY/MN | 1,152 | $31,530 | New | 13F |
| OSAIC HOLDINGS, INC. | 920 | $25,180 | New | 13F |
| PRICE T ROWE ASSOCIATES INC /MD/ | 751,947 | $20,581 | New | 13F |
| Parallel Advisors, LLC | 550 | $15,054 | New | 13F |
| Rialto Wealth Management, LLC | 508 | $13,904 | New | 13F |
| Longaeva Partners L.P. | 500 | $13,685 | New | 13F |
| Bell Investment Advisors, Inc | 451 | $12,344 | New | 13F |
| EverSource Wealth Advisors, LLC | 261 | $7,144 | New | 13F |
| MORGAN STANLEY | 200 | $5,474 | New | 13F |
| Atlantic Union Bankshares Corp | 180 | $4,927 | New | 13F |
| JONES FINANCIAL COMPANIES LLLP | 103 | $2,966 | New | 13F |
| Allworth Financial LP | 100 | $2,737 | New | 13F |
| FIFTH THIRD BANCORP | 60 | $1,641 | New | 13F |
| Physician Wealth Advisors, Inc. | 59 | $1,615 | New | 13F |
| North Star Investment Management Corp. | 52 | $1,423 | New | 13F |
| Cornerstone Financial Management LLC | 29 | $794 | New | 13F |
| Bogart Wealth, LLC | 19 | $520 | New | 13F |
| Avion Wealth | 69 | $1 | New | 13F |
Questions and answers
- How many institutions hold Parabilis Medicines, Inc.?
- 79 managers reported Parabilis Medicines, Inc. on Form 13F for the quarter ended 30 June 2026.
- Who is the largest institutional holder of Parabilis Medicines, Inc.?
- RA CAPITAL MANAGEMENT, L.P., with 28,933,371 shares worth $792 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Parabilis Medicines, Inc. in Q2 2026?
- 79 managers reported a new position and 0 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Parabilis Medicines, Inc., Q2 2026", https://app.tamarly.ai/holders/parabilis-medicines, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.